$3.33
-0.10-2.92%
At close: -
$3.36
0.030.90%
After Hours: Jan 17, 7:48 PM EDT
Comments
Loading...
Kyverna Therapeutics (NASDAQ:KYTX) Stock, Earnings Estimates, EPS, And Revenue
Kyverna Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 12
EPS Estimate
$-0.790
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Kyverna Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Kyverna Therapeutics (KYTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $-0.80 | $-0.80 | 0.00 % |
| Q2 | 2024-08-12 | $-0.67 | $-0.64 | -4.69 % |
| Q1 | 2024-05-14 | $-1.12 | $-0.84 | -33.3 % |
Kyverna Therapeutics (KYTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Kyverna Therapeutics (NASDAQ:KYTX) reporting earnings?
Kyverna Therapeutics (KYTX) is scheduled to report earnings on February 12, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Kyverna Therapeutics (NASDAQ:KYTX)?
The Actual EPS was $-0.80, which hit the estimate of $-0.80.
What were Kyverna Therapeutics’s (NASDAQ:KYTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.